Loading...
XNAS
SRTS
Market cap64mUSD
Dec 05, Last price  
3.90USD
1D
-2.99%
1Q
20.74%
Jan 2017
-25.71%
IPO
-38.29%
Name

Sensus Healthcare Inc

Chart & Performance

D1W1MN
XNAS:SRTS chart
P/E
9.64
P/S
1.53
EPS
0.40
Div Yield, %
Shrs. gr., 5y
0.16%
Rev. gr., 5y
8.93%
Revenues
42m
+71.31%
10,478,9205,810,20510,273,09414,811,17520,587,82726,427,19027,263,2489,576,93227,042,00044,532,00024,405,00041,807,000
Net income
7m
+1,270.52%
107,627-3,699,470-237,267-346,448-3,710,514-2,022,761-1,154,286-4,715,3134,119,00024,244,000485,0006,647,000
CFO
-831k
L-61.26%
255,935-128,693-1,867,682-1,339,343-851,024-3,056,606-8,563,731-2,106,642-434,180-286,000-1,412,000-2,145,000-831,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
IPO date
Jun 03, 2016
Employees
42
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT